Safety of Teriflunomide in Chinese Adult Patients with Relapsing Multiple Sclerosis: A Phase IV, 24-Week Multicenter Study.
Chinese medical journal（2024）
关键词
Teriflunomide,ABCG2 c.421C>A,Multiple sclerosis,Non randomized,Population pharmacokinetics,Safety
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要